Carbiotix AB

Investor

Carbiotix AB

Description

biotechnology company focused on gut health solutions

Carbiotix AB

Address

ScheelevÀgen 22, Lund 22363
Lund, Sweden

Contact

info@carbiotix.com

Description

biotechnology company focused on gut health solutions

Matchmaking

Connect with Carbiotix AB

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL

Carbiotix AB last news

04/04/2024

Carbiotix commences NutraCycle pilot study with leading US food & beverage producer - TradingView

27/03/2024

Impala Nordic: Carbiotix: Erik Deaner presenterar på Impala Invests investerarträff i Göteborg (MFN) - Aktiellt

[...] Om placeringar frĂ„n Swedbank och Sparbankerna Logga in TELEGRAM FRÅN MFN Onsdagen den 27 mars 2024 kl. 17:00 MFN 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Fler telegram DAGENS ANALYSERMĂ„ndag 8 april Aker BPFörsĂ€ljningsuppdatering Q1 och övrigt PGSHar fĂ„tt ett stort multikunds-kontrakt (tio mĂ„nader pĂ„ 80-90 miljoner dollar) SSABVd:n Martin Lindqvist lĂ€mnar företaget Paradox InteractiveBevakning upphör MTGBevakning upphör Enad global 7Bevakning upphör EvolutionBevakning upphör IndutradeBevakning upphör VestumBevakning upphör LifcoBevakning upphör StorskogenBevakning upphör G5 EntertainmentBevakning upphör BravidaInför Q1: överskuggad av de senaste nyheterna Nanoform2025 borde bli spĂ€nnande EuroprisGoda möjligheter inom ÖoB Clas OhlsonSvagare försĂ€ljning i mars, frĂ€mst pĂ„ grund av kalendereffekten Danske bankViktiga slutsatser frĂ„n samtalet inför rapportenDagens analyser 8 aprilArkivet för Dagens analyserPrenumerera pĂ„ MorgonrĂ„det Rekommendationslistan Vilken potential eller nedsida Ă€r det till riktkurs? Vilken rekommendation har bolaget? Aktiefiltrering med nyckeltal för daglig inspiration. Rekommendationslistan 8 apr SĂ„ fĂ„r du tillgĂ„ng till all analys i AktielltLĂ€s mer Swedbank-TVUtblick - inflationssiffror och rĂ€ntespekulationerUtblick - toppnivĂ„er, techfeber och rĂ€ntebanorUtblick - tung centralbanks- och makroveckaUtblick - Investeringsstrategi - med vinterdĂ€ck i vĂ„rsolenUtblick - vĂ„rkĂ€nslor pĂ„ börsernaFler sĂ€ndningar Utblick PĂ„ tisdagar sĂ€nder vi Utblick dĂ€r vĂ„ra strateger, analytiker och experter ger sin syn pĂ„ det aktuella marknads- och omvĂ€rldslĂ€get. Inflationssiffror och rĂ€ntespekulationerSe senaste sĂ€ndningenPrenumerera pĂ„ UtblickHitta fler Utblick i Swedbank-TV SWEDBANK ROBURTopp 5Se alla vĂ„ra fonder ÖVRIGA ANALYSER FokusportföljenAFRYAlimakAssa AbloyAtlas CopcoBalder
 +13 bolag till Fokusportföljen 26 marPrenumerera pĂ„ Fokusportföljen SektorfavoriterTotalt ingĂ„r 20 bolag.Sektorfavoriter 2 aprPrenumerera pĂ„ Sektorfavoriter Nordiska favoriterTotalt ingĂ„r 5 bolag.Nordiska favoriter 4 aprPrenumerera pĂ„ Nordiska favoriter TEKNISK ANALYS OMXS30PrismĂ€ssig balans PrismĂ€ssig balans vid prisobjektiv,..samtidigt som förhöjd rekylrisk kvarstĂ„r,..men börsen Ă€nnu strukturellt efterfrĂ„gestyrd.OMXS30-analys 27 marPrenumerera pĂ„ OMXS30 MARKNADSSENTIMENT Extrem börsoptimismVecka 14 SWEDBANK TRADINGPrenumerera pĂ„ AffĂ€rsidĂ©er Swedbanks Investeringsstrategi MARS 2024 Vi behĂ„ller vĂ„r mĂ„ttliga övervikt i aktier, som fortsatt finansieras av undervikt i krediter.Med vinterdĂ€ck i vĂ„rsolenSammanfattningPrenumerera pĂ„ strateginTill Arkivet Swedbank Economic OutlookKonjunkturprognos januari WEBBINARIUM FONDER Revansch för Ny Teknik? Onsdag 24 april 2024 [...]

20/03/2024

Carbiotix rebrands prebiotic ingredient CarbiAXOS to Carbersol

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the Company has decided to rebrand its prebiotic ingredient CarbiAXOS to Carbersol. This rebranding decision aims to better reflect current and future prebiotic products that Carbiotix will focus on, in addition to accelerating time to market for different prebiotic products. Carbiotix will update its website in the coming days to reflect this change as well as other recent news. Erik Deaner, CEO of Carbiotix, comments: "The decision to rebrand our prebiotic ingredient CarbiAXOS to Carbersol at this time is very logical.